Episode 30. Management of High-Risk Myeloma
Blood Cancer Talks
00:00
Treatment options for high-risk myeloma and the role of autologous transplant
This chapter explores the various treatment options available for high-risk myeloma patients, including the use of carfilzumib or bortezumib in induction therapy. It discusses the advantages of using bortezumib, such as its availability and administration method. The chapter also delves into the question of whether autologous transplant holds the same benefits for high-risk patients and emphasizes the importance of MRD negativity in transplant efficacy.
Transcript
Play full episode
